Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
The primary objective of the study is to evaluate the impact on quality of life of Lanreotide Autogel 120 mg in combination with standard care, in comparison to the standard care alone, in subjects affected by inoperable malignant bowel obstruction.
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
- 05 février 2025 - 1 mn de lecture
The primary objective of the study is to evaluate the impact on quality of life of Lanreotide Autogel 120 mg in combination with standard care, in comparison to the standard care alone, in subjects affected by inoperable malignant bowel obstruction.
En rapport Clinical Trials

05 février 2025
1 mn de lecture
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?

05 février 2025
1 mn de lecture
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression

05 février 2025
1 mn de lecture
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

05 février 2025
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Follow-on Study

05 février 2025
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Follow-on Study

05 février 2025
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Study

05 février 2025
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Study

05 février 2025
1 mn de lecture
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

05 février 2025
1 mn de lecture
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines

05 février 2025
1 mn de lecture